ZDA
LKFT

Zweig-DiMenna Associates’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Zweig-DiMenna Associates’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-171,840
Closed -$7M – 264
2015
Q3 		$7M Buy
171,840
+31,840
+23% +$1.83M 0.3% 91
2015
Q2 		$7.21M Buy
+140,000
New +$7.43M 0.4% 70

Other funds holding LKFT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Zweig-DiMenna Associates's LKFT Position: Q4 2015 in Review

Zweig-DiMenna Associates sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2015, closing a stake of 171,840 shares — an estimated $7M sold.

Zweig-DiMenna Associates first reported a position in LKFT in Q2 2015 and held it in 2 quarters. The position peaked at $7.21M in Q2 2015. 44 funds tracked by Wall St. Rank hold LKFT as of Q4 2015.

  • Zweig-DiMenna Associates reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2015 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 171,840 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2015, an estimated $7M.
  • Zweig-DiMenna Associates first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 2 quarters.
  • Zweig-DiMenna Associates's Lakefront Biotherapeutics American Depositary Shares position peaked at $7.21M in Q2 2015.
  • 44 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2015.

Based on Zweig-DiMenna Associates's 13F filing for Q4 2015, filed 10 Feb 2016.